til-20241231

FALSE0001789769FY20240.05http://instilbio.com/20241231#AccruedLiabilitiesAndOtherLiabilitiesCurrenthttp://instilbio.com/20241231#AccruedLiabilitiesAndOtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrentiso4217:USDxbrli:sharesiso4217:USDxbrli:sharestil:institutiontil:segmentxbrli:puretil:optiontil:vote00017897692024-01-012024-12-3100017897692024-06-2800017897692025-02-2800017897692024-12-3100017897692023-12-3100017897692023-01-012023-12-310001789769us-gaap:CommonStockMember2022-12-310001789769us-gaap:AdditionalPaidInCapitalMember2022-12-310001789769us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001789769us-gaap:RetainedEarningsMember2022-12-3100017897692022-12-310001789769us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001789769us-gaap:RetainedEarningsMember2023-01-012023-12-310001789769us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001789769us-gaap:CommonStockMember2023-12-310001789769us-gaap:AdditionalPaidInCapitalMember2023-12-310001789769us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001789769us-gaap:RetainedEarningsMember2023-12-310001789769us-gaap:CommonStockMember2024-01-012024-12-310001789769us-gaap:AdditionalPaidInCapitalMember2024-01-012024-12-310001789769us-gaap:RetainedEarningsMember2024-01-012024-12-310001789769us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-12-310001789769us-gaap:CommonStockMember2024-12-310001789769us-gaap:AdditionalPaidInCapitalMember2024-12-310001789769us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001789769us-gaap:RetainedEarningsMember2024-12-310001789769country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:CashAndCashEquivalentsMember2024-01-012024-12-310001789769country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:CashAndCashEquivalentsMember2024-01-012024-12-310001789769til:LaboratoryEquipmentMember2024-12-310001789769us-gaap:EquipmentMember2024-12-310001789769us-gaap:OfficeEquipmentMember2024-12-310001789769us-gaap:BuildingMember2024-12-310001789769us-gaap:FairValueInputsLevel2Membertil:BuildingsAndConstructionInProgressMember2024-01-012024-12-310001789769us-gaap:FairValueInputsLevel2Membertil:BuildingsAndConstructionInProgressMember2023-01-012023-12-310001789769til:RestructuringPlanMember2024-01-012024-12-310001789769til:RestructuringPlanMember2023-01-012023-12-310001789769us-gaap:LeaseholdImprovementsMember2024-01-012024-12-310001789769us-gaap:LeaseholdImprovementsMember2023-01-012023-12-310001789769us-gaap:LandMember2023-01-012023-12-3100017897692023-12-072023-12-070001789769til:ReportableSegmentMember2024-01-012024-12-310001789769til:ReportableSegmentMember2023-01-012023-12-310001789769country:US2024-12-310001789769country:US2023-12-310001789769country:GB2024-12-310001789769country:GB2023-12-310001789769us-gaap:LandMember2024-12-310001789769us-gaap:LandMember2023-12-310001789769til:LaboratoryEquipmentMember2023-12-31

SEC Form 10-K filed by Instil Bio Inc.